KRAS G12C inhibitor 29
Product Specifications
UNSPSC Description
KRAS G12C inhibitor 29 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 3. KRAS G12C inhibitor 29 can be used for the research of cancer[1].
Target Antigen
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein;MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-29.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CC2=C(F)C=CC=C2Cl)N(C)C3=C(N4C(N(C5=CC=CC(C)=C5)CCC4)=N3)C1=O
Molecular Weight
453.90
References & Citations
[1]Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-142478/KRAS-G12C-inhibitor-29-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-142478/
Clinical Information
No Development Reported
CAS Number
847337-63-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items